Published: April 24, 2018

Introduction {#sec1}
============

An ultimate goal of much of modern neuroscience is to understand the function of the human brain, and in particular the human neocortex, which expanded and differentiated substantially during mammalian evolution, mediates many of the capacities that distinguish us from our closest relatives and also plays a central role in psychiatric disorders of human patients ([@bib12], [@bib28], [@bib29]). Virtually all computations in neocortical circuits are controlled and shaped by the complement of inhibitory interneurons. Different interneuron types show distinct marker expression, physiology, and connectivity with postsynaptic targets and thereby control distinct aspects of circuit function ([@bib22], [@bib47], [@bib33], [@bib38]). Comparative studies with rodents have revealed that the primate neocortex comprises interneuron types with unique morphologies, along with a greater proportion of interneurons in general and differences in the developmental origin of these cells ([@bib12], [@bib36]). However, despite a few notable exceptions ([@bib19], [@bib40], [@bib30]), we know very little about the physiology and circuit function of distinct human interneuron types.

Here, we take advantage of a well-established source of live slices from human temporal neocortex ([@bib14], [@bib44], [@bib42]) to determine the functional features of human layer 1 interneurons (L1-INs). In rodents, a hallmark of these cells is their strong expression of nicotinic acetylcholine receptors ([@bib8], [@bib5], [@bib25], [@bib1], [@bib3]), and recent work has shown that these currents are a necessary prerequisite for rapid recruitment of L1-INs, as well as vasoactive intestinal polypeptide (Vip)-expressing cells, by endogenous acetylcholine released during learning, locomotion, and attention ([@bib25], [@bib1], [@bib32], [@bib16], [@bib33], [@bib26], [@bib23]). A second candidate neuromodulator for similar rapid responses is serotonin released from raphe nucleus afferents, which are enriched in layer 1 ([@bib43]) and thought to predominantly contact interneurons ([@bib7]). The HTR3 receptor is the only known fast, ionotropic serotonin receptor, which in rodents is expressed in approximately 10% of L1-INs in frontal cortex ([@bib50]), and the majority in somatosensory cortex ([@bib24]). How recruitment by these neuromodulators affects the circuit depends on L1-IN connectivity. Two physiologically and molecularly distinct types of L1-INs have been identified in rodents ([@bib48], [@bib9], [@bib41], [@bib11], [@bib51]), which display differential connectivity in the local circuit ([@bib20], [@bib21]) and potentially different functions *in vivo* ([@bib31], [@bib26]). Here, we determine these attributes in human neocortex and present analogous, age- and area-matched data from wild-type and transgenic mice (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}) to directly link our findings to the large and dynamic rodent literature.

Results {#sec2}
=======

Nicotinic Responses in Human Temporal Neocortex Layer 1 Interneurons {#sec2.1}
--------------------------------------------------------------------

Exploiting the fact that L1-INs can be robustly targeted without genetic markers, we obtained whole-cell recordings in acute slices of healthy human temporal neocortex that needed to be removed to gain access to the underlying pathology and was donated by adult patients (10 male, 3 female, age range 19--52 years, average 36.6 ± 2.9). Layer 1 was identified as the area of low cell density immediately below the pia mater ([Figure 1](#fig1){ref-type="fig"}A), and post hoc analyses of neuron density ensured that only neurons located more than 20 μm from the L1/L2 border were included in the dataset.Figure 1Nicotinic Responses in Human Layer 1 Interneurons(A) Neuron density relative to the pia was used to define layer 1 in human (green, 7 slices, 3 patients) and mouse neocortex (red, 29 slices, 3 mice) (A~1~, A~2~). Layer 1 thickness was 254.2 ± 16.3 μm for human and 90.7 ± 2.0 μm for mouse (A~3~).(B) All human and mouse L1-INs showed rapid voltage responses to local pressure application of acetylcholine, and displayed supra- or subthreshold responses in similar proportions (p = 0.25, Fisher's exact test) (B~1~). Nicotinic currents showed biphasic time courses in approximately half of the human and mouse cells (top left), with a rapid, large amplitude initial current and a slower second component (B~2~). A second major L1-IN fraction displayed exclusively slow currents (bottom left), while the remaining minority showed only the rapid component (center). The proportion of these response types was similar in human and mouse (right, p = 0.58, Fisher exact test). (B~3~) The charge of nicotinic responses was similar in the two species (p = 0.39, Kruskal-Wallis test, n = 21 versus n = 46, −88.2 ± 15.5 versus −69.3 ± 8.2 pC).(C and D) Bath application of the selective α7 receptor antagonist MLA (10 nM) abolished the fast current in human (C~1~) and mouse (D~1~) L1-INs with biphasic currents. C~3~, D~3~ MLA reduced the response charge in humans (p \< 0.05, n = 5, Wilcoxon signed-rank test, −150.4 ± 27.3 versus −119.2 ± 22.0 pC) and mice (p \< 0.05, n = 5, Wilcoxon signed-rank test, −97.6 ± 20.0 versus −60.0 ± 7.9 pC), although its effect on peak amplitude was more pronounced ([Figure S1](#mmc1){ref-type="supplementary-material"}). The β2-containing receptor antagonist DHBE (1 μM) selectively blocked the slow current (C~2~, D~2~), which carried most of the charge in humans (C~4~, p \< 0.01, n = 7, Wilcoxon signed-rank test, −118.2 ± 22.7 versus −12.1 ± 2.4 pC, tested on 3 biphasic and 4 monophasic slow currents, see [Figure S1](#mmc1){ref-type="supplementary-material"}) and mice (D~4~, p \< 0.01, n = 8, Wilcoxon signed-rank test, −66.5 ± 12.0 versus −8.25 ± 4.1 pC, tested on 1 biphasic and 7 monophasic slow currents). Error bars indicate SEM. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To address whether human L1-INs express nicotinic receptors, we pressure applied acetylcholine (1 mM) in the presence of the muscarinic antagonist atropine (400 nM). All L1-INs tested in current clamp (n = 12) were depolarized by acetylcholine, with the majority showing suprathreshold responses (8 out of 12 neurons, [Figures 1](#fig1){ref-type="fig"}B1 and [S1](#mmc1){ref-type="supplementary-material"}). Voltage-clamp recordings revealed that many L1-INs displayed clearly bi-phasic nicotinic currents (10 out of 21), with a rapid component and a much slower second component ([Figure 1](#fig1){ref-type="fig"}B2). The remaining L1-INs had either exclusively slow (n = 8) or fast nicotinic currents (n = 3). Consistent with observations from other areas of rodent cortex ([@bib8], [@bib5]), comparison recordings from temporal neocortex of adult mice produced very similar results ([Figures 1](#fig1){ref-type="fig"} and [S1](#mmc1){ref-type="supplementary-material"}).

To define the nicotinic acetylcholine receptor subtypes mediating these responses, we used pharmacology. In both species, the rapid component of biphasic cholinergic currents was blocked by methyllycaconitine (MLA; 10 nM, [Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}), identifying α7 receptors as the underlying conductance ([@bib46]). In contrast, the slow component of biphasic currents, and slow monophasic currents were completely abolished by dihydro-beta-erythroidine (DHBE; 1 μM, [Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}), indicating β2-containing heteromeric receptors ([@bib10]). The rapid component had a much greater amplitude in general, and in particular in mouse L1-INs ([Figure S1](#mmc1){ref-type="supplementary-material"}), whereas the slow current carried by far most charge in both species ([Figures 1](#fig1){ref-type="fig"}C and 1D, cf. [@bib5]). While the rise time of α7 currents was indistinguishable between human and mouse L1-INs, the slow current displayed both longer rise and decay times in human L1-INs ([Figure S1](#mmc1){ref-type="supplementary-material"}), which may suggest differential modulation or subcellular localization of the receptors or could alternatively be due to morphological differences. Importantly, we could not detect an impact of the patients' smoking history on these currents (p \> 0.05 for Kruskal-Wallis tests on response amplitude and charge when comparing current or former smokers with non-smokers), in contrast to larger and more prevalent nicotinic currents in layer 6 pyramidal neurons of smokers ([@bib45]). Taken together, these results indicate that human L1-INs display strong expression of α7 and β2-containing nicotinic acetylcholine receptors, consistent with similar observations in unidentified human interneurons ([@bib2]), and with the high density of nicotine binding sites in human layer 1 ([@bib37]). Interestingly, fast α7 receptors have been suggested to mediate rapid cholinergic synaptic transmission ([@bib5], [@bib39]), while the slower currents through β2-containing receptors are likely recruited by a form of volume transmission, indicating that a large fraction of L1-INs may thus be recruited by both modes of cholinergic signaling. Together with their pronounced excitability ([Figure 3](#fig3){ref-type="fig"}, see below), and the enrichment of cholinergic synapses in human layer 1 ([@bib39]), our results thus indicate that L1-INs can be rapidly recruited by endogenous acetylcholine release during arousal, attention, and learning in the intact human brain in a fashion similar to that found in behaving mice ([@bib4], [@bib33], [@bib26]).

Conserved Absence of HTR3 Responses in Human Layer 1 Interneurons {#sec2.2}
-----------------------------------------------------------------

A second candidate ionotropic receptor for fast neuromodulation is the serotonin HTR3 receptor, which in rodents is expressed in approximately 10% of L1-INs in frontal cortex ([@bib50]), and the majority in somatosensory cortex ([@bib24]). In human L1-INs, pressure application of the selective HTR3 receptor agonist mCPBG (100 μM) yielded no detectable current ([Figure 2](#fig2){ref-type="fig"}A, n = 10), and similar results were observed when using serotonin ([Figure S2](#mmc1){ref-type="supplementary-material"}, n = 6). As a control for recording conditions, we verified that acetylcholine elicited robust responses in a subset of these experiments ([Figure 2](#fig2){ref-type="fig"}A). Similar to the human data, L1-INs in adult mouse temporal neocortex displayed no response to mCPBG ([Figure 2](#fig2){ref-type="fig"}A, n = 10). These data suggest that in both species, the large majority of L1-INs is not under rapid control by serotonin.Figure 2Conserved Absence of HTR3 Responses in Human Layer 1 Interneurons(A) Pressure application of the selective Htr3 receptor agonist mCPBG (100-ms application displayed, 1 s and 10 s also tested) caused no response in L1-INs of either species, in contrast to robust responses when acetylcholine was applied to the same cells (inset, 10-s application) (A~1~). On average, the *Htr3* receptor mediated charge was 1.81 ± 0.82 pC in human (n = 10), and 0.53 ± 1.01 pC in mouse (n = 10), and similar data were obtained with application of serotonin (A~2~) ([Figure S2](#mmc1){ref-type="supplementary-material"}).(B) *In situ* hybridization for *HTR3A* in human (B~1~) and mouse neocortex (B~2~). Note that while the density peaks in layer 2/3, a small population of positive neurons is also present in layer 1. The image in B~1~ is a montage of images assembled using Pannoramic Scan software.(C) Vip positive interneurons in layer 1 and layer 2/3 were targeted using a cross of transgenic mouse lines. Example responses of a Vip positive and negative L1-IN to mCPBG application. While Vip negative L1-INs showed no response, Vip positive L1-INs and L2-3-INs displayed large inward currents that led to robust firing (inset). Similar data were obtained with application of serotonin ([Figure S2](#mmc1){ref-type="supplementary-material"}) (C~1~). The average charge of mCPBG responses in Vip negative L1-INs was 0.13 ± 1.86 pC (n = 6), whereas Vip positive interneurons in layer 1 and layer 2/3 displayed responses of −69.88 ± 0.30 pC (n = 8, p \< 0.01, Kruskal-Wallis test). Error bars indicate SEM (C~2~ ).See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

However, the number of recordings presented here (n = 26 in total) does not rule out the presence of a small population of responsive L1-INs as reported for rat frontal cortex ([@bib50]). Consistent with this, *in situ* hybridization in human and mouse temporal neocortex indicated that, while most *Htr3a* receptor positive neurons are located in layer 2/3, there is also expression in a small set of L1-INs ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}). We hypothesized that these could be Vip-positive interneurons, which express Htr3a receptors ([@bib15], [@bib24]) and represent a small population of L1-INs in mouse neocortex ([@bib35], [@bib49]). Recordings from Vip interneurons in a cross of transgenic mouse lines revealed robust inward currents in response to mCPBG and serotonin both in layer 1 and layer 2/3 ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}). In contrast, unlabeled, Vip negative L1-INs displayed no response. In line with this result, Vip expression in human and mouse neocortex recapitulates the *Htr3a* profile and is confined to a small population of L1-INs ([Figure S3](#mmc1){ref-type="supplementary-material"}). In conclusion, these data suggest that, while all L1-INs respond to acetylcholine, only the small subset that expresses VIP is under dual control by the serotonergic and cholinergic systems in both species.

Intrinsic Properties of Human Layer 1 Interneurons {#sec2.3}
--------------------------------------------------

The intrinsic physiological properties of human L1-INs determine how neuromodulatory input is converted to circuit modulation by these cells. Our data indicate that human L1-INs (n = 46) display a markedly steeper input-output function compared to the mouse (n = 66), with more than twice the action potential frequency across the whole range of injected current and significantly lower rheobase ([Figures 3](#fig3){ref-type="fig"}A--3C and [S4](#mmc1){ref-type="supplementary-material"}). Both higher input resistance and lower action potential threshold of human L1-INs contribute to this effect, while we find no difference in resting membrane potential. In addition, we observe differences in several other intrinsic parameters, including voltage sag and spike frequency accommodation that are of interest for mechanistic models of human neocortex ([Figure S4](#mmc1){ref-type="supplementary-material"}). Importantly, we found no indication that the disease history of human patients had an impact on these results ([Figure S4](#mmc1){ref-type="supplementary-material"}). Consistent with this, greater excitability, lower action potential threshold, and higher input resistance and voltage sag have been reported in a study comparing layer 2/3 neurogliaform cells from healthy macaque and rat ([@bib34]). Together, this suggests that these properties represent specializations of certain types of primate interneurons that need to be taken into account when modeling the human neocortex.Figure 3Intrinsic Properties and Subtypes of Human Layer 1 Interneurons(A) Responses of example human (green) and mouse (red) L1-IN to current injections of −100, +25, and +75 pA (inset).(B) Human neurons fired at higher frequencies across the entire range of injected currents (p \< 0.001 for all current amplitudes, Kruskal-Wallis test, n = 46 human neurons and n = 66 mouse neurons).(C) While the resting membrane potential of human and mouse L1-INs was similar (Vrest, −65.2 ± 0.7 versus −66.4 ± 0.8 mV, Kruskal-Wallis test, p = 0.28), human neurons displayed higher input resistance (286.0 ± 14.9 versus 208.4 ± 8.9 MΩ, Kruskal-Wallis test, p \< 0.001) and lower action potential threshold compared to mice (−40.4 ± 0.5 versus −36.4 ± 0.7 mV, Kruskal-Wallis test, p \< 0.001), with both factors likely contributing to the greater excitability of human L1-INs.(D) These parameters showed no correlation with the disease history of the patients (p \> 0.2, see also [Figure S4](#mmc1){ref-type="supplementary-material"}).(E) (left) Unsupervised hierarchical clustering on a set of active and passive physiological properties (Ward's method on normalized datasets without prior assumption on cluster number) yielded a non-late-spiking and a late-spiking cluster in the mouse, which also differ in most other parameters (table presents mean, SEM and results of Kruskal-Wallis test). In addition to differences in spiking accommodation, voltage sag, and action potential afterhyperpolarization ([@bib9], [@bib41], [@bib20], [@bib21]), the late-spiking L1-INs display more depolarized action potential threshold, faster membrane time constant and lower action potential amplitude. (Right) The same unbiased analysis on human L1-INs yielded similar clusters, with a population of late-spiking cells that display smaller voltage sag, more depolarized action potential threshold, and faster membrane time constant. In addition, input resistance and resting membrane potential displayed similar trends in both species, whereas spiking accommodation, action potential afterhyperpolarization, and amplitude varied in a distinct manner between the two clusters in mouse and human. Calibration bar indicates value rank between 0 and 1.(F) Example firing patterns. Error bars indicate SEM.See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

Conserved Interneuron Subtypes and Marker Expression in Human Layer 1 {#sec2.4}
---------------------------------------------------------------------

Rodent data have shown that L1-INs can be further divided into physiological subtypes ([@bib48], [@bib9], [@bib41]), which display differential connectivity in the local circuit ([@bib20], [@bib21]) and potentially different functions *in vivo* ([@bib26]). To address whether human L1 comprises similar interneuron subtypes in an unbiased way, we employed unsupervised hierarchical clustering on a comprehensive set of active and passive physiological properties ([Figure 3](#fig3){ref-type="fig"}E). For the mouse, this analysis defined two clusters that differ in 7 parameters and correspond to the well-described rodent late-spiking and non-late-spiking L1-INs characterized by differences in latency of the first action potential at rheobase, as well as in spike frequency accommodation, voltage sag, and action potential afterhyperpolarization ([@bib9], [@bib41], [@bib20], [@bib21]). The same analysis on human data yielded two clusters that differ in action potential latency, indicating that late-spiking and non-late-spiking interneurons are also present in layer 1 of human neocortex ([Figures 3](#fig3){ref-type="fig"}E and 3F). Out of the remaining 9 parameters, 3 showed a corresponding cluster distribution in both species (voltage sag, action potential threshold, membrane time constant), and 2 showed a trend for similarity (input resistance, resting membrane potential), whereas spike frequency accommodation, action potential afterhyperpolarization, and amplitude were clearly distinct between the clusters across species, as well as between human and mouse L1-INs in general ([Figure S4](#mmc1){ref-type="supplementary-material"}). There was no difference in action potential latency between human and mouse late-spiking or non-late-spiking cells (p \> 0.05, Kruskal-Wallis test). No detectable difference was in addition observed in nicotinic responses between late-spiking and non-late-spiking L1-INs of either species ([Figure S5](#mmc1){ref-type="supplementary-material"}), indicating that both types are under similar cholinergic control. Interestingly, most rodent analyses of late-spiking interneurons have reported little firing accommodation ([@bib9], [@bib20], [@bib21]), potentially suggesting that late-spiking, accommodating L1-INs are a specialization of human neocortex that may be mechanistically related to the larger voltage sag of these cells ([Figure S4](#mmc1){ref-type="supplementary-material"}).

These results indicate that human layer 1 comprises two distinct types of interneurons, which share a range of properties with the respective populations in mice. To address whether this conservation extends to the molecular identity of L1-INs, we utilized neuron-derived neurotrophic factor (Ndnf), a recently described, selective genetic marker for mouse L1 neurogliaform interneurons in visual cortex ([@bib41]). Intriguingly, *in situ* hybridization revealed that *NDNF*-expressing cells are highly enriched in human layer 1, with a steep drop in density at the border to layer 2 ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}). Mouse neocortex showed a very similar expression profile ([Figures 4](#fig4){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}), and we next used a transgenic mouse line expressing eGFP under the Ndnf promoter ([@bib17]) to determine how Ndnf-positive L1-INs relate to the two interneuron subtypes identified in unbiased recordings ([Figure 3](#fig3){ref-type="fig"}). Among other properties, Ndnf-positive L1-INs showed long action potential onset latencies, little spiking accommodation, and large action potential afterhyperpolarization ([Figures 4](#fig4){ref-type="fig"}B--4D), very similar to the late-spiking cluster. Moreover, a quantitative comparison revealed that Ndnf-positive L1-INs differ from the non-late-spiking cluster in the same properties as the late-spiking cluster, whereas no differences between Ndnf-positive L1-INs and the late-spiking cluster were found ([Figures 4](#fig4){ref-type="fig"}B--4D). The observed convergence between marker expression and clustering as two independent approaches provides strong evidence that late-spiking L1-INs are Ndnf-positive neurogliaform cells and highlights the power and sensitivity of a clustering approach based on a comprehensive set of properties. Taken together, these data indicate that human neocortex expresses a conserved marker for L1 neurogliaform cells and comprises a population of late-spiking interneurons, suggesting that human layer 1 contains a set of neurogliaform cells or a physiologically and genetically related interneuron type. In turn, identification of NDNF will facilitate future research on these interneurons, for instance, by enabling postmortem analyses in different brain disorders and more precise translation of mouse data to the human brain.Figure 4Neuron-Derived Neurotrophic Factor Is a Conserved Marker for Human Layer 1 Neurogliaform Cells(A) *In situ* hybridization for *NDNF* in human neocortex (left) and quantification of the distribution of positive neurons along cortical depth (12 slices from 2 patients). The density of *NDNF*-positive neurons is high in layer 1 (light gray) and drops off steeply at the border to layer 2 (dark gray) (A~1~). *In situ* hybridization for *Ndnf* in mouse temporal neocortex (16 slices from 3 animals) shows a similar expression profile, indicating that *Ndnf* is a conserved marker for layer 1 interneurons (A~2~). The image in A~1~ is a montage of images assembled using Pannoramic Scan software.(B) Whole-cell current-clamp slice recording using an Ndnf-eGFP mouse line.(C) To determine whether Ndnf positive layer 1 interneurons correspond to one of the populations identified by unbiased clustering of the entire layer 1 interneuron population ([Figure 3](#fig3){ref-type="fig"}), we compared the distribution of action potential onset (C~1~), spiking accommodation (C~2~), and action potential afterhyperpolarization (C~3~) in the three populations. Ndnf interneurons display robust similarity with the late-spiking cluster in all three parameters.(D) Statistical comparison of the 10 attributes used for clustering between the three populations indicates that Ndnf interneurons and cells in the late-spiking cluster differ from the non-late-spiking cluster in the same properties, whereas no difference could be detected between the late-spiking and Ndnf populations. Error bars indicate SEM.

Discussion {#sec3}
==========

Layer 1 is the unique site in neocortex where a variety of long-range projections from cortical, higher-order thalamic and neuromodulatory sources impinges onto the apical dendrites of local pyramidal neurons and the sparse set of L1-INs ([@bib6], [@bib13]). In line with this organization, recent data from rodents indicate that L1-INs in sensory cortex are specialized for encoding contextual information such as primary reinforcers ([@bib25]), interhemispheric interactions ([@bib31]), and multimodal processing ([@bib18]). While a mechanistic understanding of such processes in the human brain is still elusive, our aim here was first to determine the functional properties of human L1-INs and second to test to what extent data from the mouse---where further rapid progress is expected due to a range of high-resolution *in vivo* approaches---is relevant to the function of human neocortex. In contrast to recent studies reporting differences between human and rodent pyramidal neurons in terms of membrane properties ([@bib14]), synaptic plasticity ([@bib44]), and communication ([@bib42]), our results indicate that key properties of L1-INs at the level of physiology, marker expression, and neuromodulation are conserved in human neocortex. This suggests that, despite the striking evolution of neocortical structure, and particularly of the inhibitory system ([@bib12]), L1-INs carry out comparable functions in the two species. However, future work is required to elucidate whether human non-late-spiking L1-INs show similarities to the single-bouquet cells found in the rodent ([@bib20], [@bib21]). In addition, it will be important to determine whether the two human L1-IN types can be further subdivided based on additional markers, morphological properties, and connectivity ([@bib41], [@bib21]). Moreover, our data also reveal differences between human and mouse L1-INs, which together with a previous study comparing layer 2/3 neurogliaform interneurons between macaque and rat ([@bib34]) identify specializations of these interneuron types in the primate brain such as the greater voltage sag that can profoundly affect their physiological properties.

In addition to the evolutionary relevance, a more precise understanding of the physiology of different identified human interneurons types is also a key prerequisite for biomedical research. Maladaptive changes in both inhibitory interneurons ([@bib28], [@bib29]) and cholinergic neuromodulation ([@bib27]) are thought to be core features of a range of human brain disorders and the present results together with the available data on human fast-spiking interneurons and neurogliaform cells in deeper layers ([@bib19], [@bib40], [@bib30]) also provide a first framework for a cell-type-specific, mechanistic understanding of the underlying pathophysiology that can be used to build quantitative disease models and to evaluate the relevance of data obtained in other model systems such as tissue derived from induced pluripotent stem cells.

Experimental Procedures {#sec4}
=======================

Further details and an outline of resources used in this work can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}. All procedures on mice were performed in accordance with institutional guidelines and were approved by the Regierungspräsidium Darmstadt. All procedures on human tissue were performed with the approval of the Medical Ethical Committee of the VU University Medical Centre, and in accordance with Dutch license procedures and the declaration of Helsinki.

Brain Slice Preparation and Patch-Clamp Recordings {#sec4.1}
--------------------------------------------------

Healthy human brain tissue was obtained from anterior medial temporal cortex with written informed consent of patients undergoing surgical treatment (10 male, 3 female, age range 19--52 years, age 36.6 ± 2.9 years). Experimental mice (85 ± 5 days, age range 40--162 days) of both sexes were sacrificed by decapitation under anesthesia. Brain slices were prepared using standard procedures. Whole-cell recordings were performed at 31°C--34°C, and agonists were pressure-applied to the soma of the recorded neuron.

Analysis of Intrinsic Properties and Interneuron Subtypes {#sec4.2}
---------------------------------------------------------

Neurons were subjected to current steps (500 ms, −100 to 250 pA), and passive and active properties were determined from the resulting voltage traces. Unsupervised clustering was performed on ranked data using Ward's method.

*In Situ* Hybridization and Immunohistochemistry {#sec4.3}
------------------------------------------------

*In situ* hybridization and immunohistochemistry was performed using fluorescent labeling in mouse tissue and chromogenic staining in human cortex according to standard procedures. Cells were detected and their location relative to the pia mater was determined.

Statistics {#sec4.4}
----------

Datasets were tested for normality (Kolmogorov-Smirnov test) and subjected to the tests indicated in the text. A result was considered significant when the p value was lower than 0.05. Since effect size was unknown, sample size could not be pre-specified. No randomization procedure or blinding of experimenter was used in the experimental design.
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========================
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